NCT04725708

Brief Summary

The aim of this study is to examine the effects of different but safe levels of arterial oxygen levels used in cardiac surgeries on cerebral oxygenation during the operation. It is also to investigate the effect on cognitive functions in the postoperative period. For our study the investigators will conduct a randomized control trial. Patients will be randomly assigned to one of two possible study groups according to the arterial oxygen levels.If there is any abnormality in cerebral oxygen levels during surgery, necessary intervention will be made by doctors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 20, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 27, 2021

Completed
Last Updated

March 29, 2023

Status Verified

March 1, 2023

Enrollment Period

6 months

First QC Date

January 20, 2021

Last Update Submit

March 28, 2023

Conditions

Keywords

cardiovascular surgerycerebral oxymetreneurocognitive assessment

Outcome Measures

Primary Outcomes (5)

  • postoperative neurocognitive function

    Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.

    12 hours after surgery

  • postoperative neurocognitive function

    Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.

    24 hours after surgery

  • postoperative neurocognitive function

    Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.

    1 month after surgery

  • postoperative neurocognitive function

    Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.

    3 months after surgery

  • postoperative neurocognitive function

    Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.

    6 months after surgery

Secondary Outcomes (1)

  • Extubation time after surgery

    During the hospitalization for postoperative recovery ,average 8 days

Study Arms (2)

normoxy

EXPERIMENTAL

Group 1(n=50) FiO2%40, PaO2\<180 ve PaO2≥80mmHg MMSE will be applied to patients before surgery. At the determined measurement times body and blood temperature, SpO2, HR, MAP, PH, blood gas lactate, blood gas base deficit, urine output, PaO2, PaCO2, Htc, FiO2, right and left rSO2 values were monitored. An rSO2 less than 45% triggered an alarm, the anesthesiologist timed the event, and after 60 seconds initiated an intervention protocol means; PaO2 levels were checked, PaO2\> 100 mmHg was achieved, if not improved, pump blood flow, mean arterial pressure were increased, if there is still no response and hematocrit \<20%, patients were scheduled for erythrocyte transfusion until the rSO2 was restored to at least 60% at both probes.In the postoperative period, at the 24th hour, when routine cardiological controls were performed 1., 3., 6. Simultaneous MMSE will be repeated in months.

Procedure: procedure: cerebral oxygenation intervention

hyperoxia

EXPERIMENTAL

Group 2(n=50) FiO2%100, PaO2≥180mmHg MMSE will be applied to patients before surgery. At the determined measurement times body and blood temperature, SpO2, HR, MAP, PH, blood gas lactate, blood gas base deficit, urine output, PaO2, PaCO2, Htc, FiO2, right and left rSO2 values were monitored..In the postoperative period, at the 24th hour, when routine cardiological controls were performed 1., 3., 6. Simultaneous MMSE will be repeated in months.

Procedure: procedure: cerebral oxygenation intervention

Interventions

During the surgery, cerebral oxygenation will be followed and intervention will be made to pH, PaO2, PaCO2, mean arterial pressure, hematocrit when necessary. In addition perfusion flow was maintained at or close to between 2.2-2.5 L/min/m2 . Perfusion pressure was adjusted using a phenylephrine infusion to maintain a mean arterial pressure of 50 to 70 mm Hg.

hyperoxianormoxy

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patients scheduled to undergo elective cardiopulmonary bypass graft surgery

You may not qualify if:

  • severe preoperative cognitive impairment(i.e. dementia, intellectual disorder)
  • Non-Turkish speaking patients
  • presence of end-stage organ failure
  • patients requiring emergency coronary surgery
  • surgical procedures requiring single lung ventilation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bursa YIERH

Bursa, 16200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Neurocognitive Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Tuğba T ONUR, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    PRINCIPAL INVESTIGATOR
  • Ümran Ü KARACA, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    STUDY CHAIR
  • Filiz F ATA, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    STUDY CHAIR
  • Halil Erkan H SAYAN, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    STUDY CHAIR
  • Anıl A ONUR, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    STUDY CHAIR
  • Canan C YILMAZ, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    STUDY CHAIR
  • Ayşe Neslihan AN BALKAYA, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    STUDY CHAIR
  • Cüneyt C ERİŞ

    Bursa Yuksek Ihtisas Training and Research Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 20, 2021

First Posted

January 27, 2021

Study Start

November 1, 2019

Primary Completion

May 1, 2020

Study Completion

August 1, 2020

Last Updated

March 29, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations